Science That Changes Lives

 

On behalf of MDA, please accept our heartfelt thanks for attending the 2025 MDA Clinical & Scientific Conference.

Scientific, Clinical, and Advocacy Impact by the Numbers

• 8 specialized tracks covering the latest advancements in neuromuscular disease research and treatment.
• 39 sessions led by world-renowned experts.
• 263 in-person posters
• 379 virtual posters
• 56 oral poster presentations
• 207 speakers from leading institutions and organizations.
• 56 exhibitors, featuring the latest innovations in diagnostics, therapeutics, and patient support services.
• 20 Patient Advocacy Pavilion participants, fostering collaboration between patients, researchers, and industry partners.
• 37 advocacy organizations participated in the Neuromuscular Advocacy Collaborative (NMAC) meeting, reinforcing the importance of policy and access initiatives.
• 18 industry-sponsored forums, providing in-depth discussions on emerging treatments and care strategies.

Did you miss out on the 2025 MDA Clinical & Scientific Conference? Click here to gain access to the on-demand content.

Looking Ahead

The 2025 MDA Clinical & Scientific Conference reaffirmed MDA’s role as a leader in neuromuscular disease research, care, and advocacy. With groundbreaking science, robust discussions in genetic medicine, muscle regeneration, and a shared commitment to improving the lives of individuals and families affected by neuromuscular diseases. The momentum from this conference will drive continued progress throughout the year.

The 2026 MDA Clinical & Scientific Conference will be held in Orlando, Florida, March 8-11. Registration will be open this summer.